<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Low <z:chebi fb="3" ids="37445">folate</z:chebi> status is well recognized as one of the metabolic stressors for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e>, but its role in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> invasion remains unknown </plain></SENT>
<SENT sid="1" pm="."><plain>Activation of the Sonic hedgehog (Shh) signal in interaction with the transcription nuclear factor-kappa B (NF-κB) pathway is crucial for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> <z:hpo ids='HP_0000718'>aggressiveness</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The aims of this study were to investigate whether and how <z:chebi fb="3" ids="37445">folate</z:chebi> deprivation promotes invasion by <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells in relation to Shh signaling and NF-κB pathway activation </plain></SENT>
<SENT sid="3" pm="."><plain>Cultivation of epithelial colon <z:mp ids='MP_0002038'>carcinoma</z:mp>-derived cells (HCT116) in <z:chebi fb="3" ids="37445">folate</z:chebi>-deficient (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FD</z:e>) medium enhanced cellular migration and invasion, in correlation with epithelial-mesenchymal transition (EMT) associated with Snail expression and E-cadherin suppression, increased production of β1 integrin and increased proteolysis by matrix metalloproteinase 2 </plain></SENT>
<SENT sid="4" pm="."><plain>Blockade of Shh signaling by cyclopamine (CYC) or of NF-κB activation by BAY abolished <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FD</z:e>-enhanced EMT and invasion by HCT116 cells </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FD</z:e> cells had 50-80% less intracellular <z:chebi fb="3" ids="37445">folate</z:chebi>, associated with aberrant hypomethylation of the Shh promoter, than control cells, and increased binding of nuclear NF-κB subunit p65 to the Shh promoter region, which coincided with increased Shh expression and protein production of Shh ligand; in addition, the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FD</z:e>-induced Shh signaling targeted Gli1 transcription activator as well as Ptch receptor </plain></SENT>
<SENT sid="6" pm="."><plain>The <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FD</z:e>-induced Shh induction and activated signaling were blocked by NF-κB inhibitor BAY </plain></SENT>
<SENT sid="7" pm="."><plain>Blockade of Shh signaling abrogated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FD</z:e>-promoted NF-κB activation measured by IκBα degradation and by target gene TNFα expression </plain></SENT>
<SENT sid="8" pm="."><plain>Taken together, these findings demonstrate that <z:chebi fb="3" ids="37445">folate</z:chebi> deprivation enhanced invasiveness of <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells mediated by activation of Shh signaling through promoter hypomethylation and cross actions with the NF-κB pathway </plain></SENT>
</text></document>